Clinical Roundup Opdivo + Yervoy improves OS for advanced hepatocellular carcinoma in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Updated analyses from 3 phase III trials continue to support Opdivo and its combinations for NSCLC June 07, 2024Vol.50 No.23
Clinical Roundup Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup Obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL in phase Ib/II study June 07, 2024Vol.50 No.23
Clinical Roundup Shorter durations of venetoclax yields similar response rates in AML June 07, 2024Vol.50 No.23
Clinical Roundup Antibody-drug conjugate targeting CEACAM5 shows activity in advanced CRC in phase I study preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup USP1 inhibitor combination shows manageable safety profile, anti-tumor activity in metastatic solid tumors in phase I study preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup CM24 combination improves clinical outcomes in advanced metastatic PDAC in phase II study interim data June 07, 2024Vol.50 No.23
Clinical Roundup Studies detail molecular pathway that impacts pancreatic cancer progression and response to treatment June 07, 2024Vol.50 No.23
Clinical Roundup LGBTQ+ cancer report reveals unique stressors, discrimination likely to increase cancer risk May 31, 2024Vol.50 No.22
